0001209191-20-013029.txt : 20200226 0001209191-20-013029.hdr.sgml : 20200226 20200226163408 ACCESSION NUMBER: 0001209191-20-013029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20656272 MAIL ADDRESS: STREET 1: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001242825 LEIDEN JEFFREY M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 1 0 0 CEO & President Common Stock 2020-02-24 4 F 0 8410 239.23 D 103131 D Common Stock 2020-02-25 4 S 0 2273 229.77 D 100858 D Common Stock 2020-02-25 4 S 0 1120 230.40 D 99738 D Common Stock 2020-02-25 4 S 0 1050 231.76 D 98688 D Common Stock 2020-02-25 4 S 0 1017 232.96 D 97671 D Common Stock 2020-02-25 4 S 0 1640 234.49 D 96031 D Common Stock 2020-02-25 4 S 0 1210 235.53 D 94821 D Common Stock 2020-02-25 4 S 0 560 236.63 D 94261 D Common Stock 2020-02-25 4 S 0 1680 238.33 D 92581 D Common Stock 440 I 401(k) Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $229.77 (range $229.07 to $230.00). Open market sales reported on this line occurred at a weighted average price of $230.40 (range $230.14 to $230.73). Open market sales reported on this line occurred at a weighted average price of $231.76 (range $231.27 to $232.14). Open market sales reported on this line occurred at a weighted average price of $232.96 (range $232.27 to $233.11). Open market sales reported on this line occurred at a weighted average price of $234.49 (range $233.99 to $234.66). Open market sales reported on this line occurred at a weighted average price of $235.53 (range $235.07 to $235.72). Open market sales reported on this line occurred at a weighted average price of $238.33 (range $238.16 to $238.56). /s/ Omar White, Attorney-in-Fact 2020-02-26